The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-5-(5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-N,N-dimethylpyrimidin-2-amine ID: ALA4294032
PubChem CID: 145993870
Max Phase: Preclinical
Molecular Formula: C19H17Cl2FN4O
Molecular Weight: 407.28
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C[C@@H](Oc1cncc(-c2cnc(N(C)C)nc2)c1)c1c(Cl)ccc(F)c1Cl
Standard InChI: InChI=1S/C19H17Cl2FN4O/c1-11(17-15(20)4-5-16(22)18(17)21)27-14-6-12(7-23-10-14)13-8-24-19(25-9-13)26(2)3/h4-11H,1-3H3/t11-/m1/s1
Standard InChI Key: JCCKMFUWIMHBHD-LLVKDONJSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
2.9826 -15.1097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9814 -15.9293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6895 -16.3382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3991 -15.9288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3963 -15.1061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6877 -14.7009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6852 -13.8837 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.1025 -14.6949 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.6893 -17.1554 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5.1075 -16.3363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8145 -15.9266 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.5229 -16.3341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5196 -17.1497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2271 -17.5571 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9351 -17.1474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9312 -16.3259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2231 -15.9222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1088 -17.1535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6319 -15.9156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3420 -16.3223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0471 -15.9108 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0434 -15.0928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3286 -14.6880 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6264 -15.1018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7485 -14.6796 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.4588 -15.0837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7432 -13.8624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
5 8 1 0
3 9 1 0
4 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
10 18 1 6
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
16 19 1 0
22 25 1 0
25 26 1 0
25 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 407.28Molecular Weight (Monoisotopic): 406.0763AlogP: 5.19#Rotatable Bonds: 5Polar Surface Area: 51.14Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 4.23CX LogP: 4.60CX LogD: 4.60Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.55Np Likeness Score: -1.35
References 1. Lim JW, Kim SK, Choi SY, Kim DH, Gadhe CG, Lee HN, Kim HJ, Kim J, Cho SJ, Hwang H, Seong J, Jeong KS, Lee JY, Lim SM, Lee JW, Pae AN.. (2018) Identification of crizotinib derivatives as potent SHIP2 inhibitors for the treatment of Alzheimer's disease., 157 [PMID:30103190 ] [10.1016/j.ejmech.2018.07.071 ]